| Literature DB >> 32292932 |
Andrew Wange Bugenyi1, Ho-Seong Cho2, Jaeyoung Heo3.
Abstract
Birth weight and subsequent weight gain is of critical importance in the survival and performance of piglets on a commercial swine farm setting. Oropharyngeal microbiome could influence immunity, and feeding behavior thus impacting health and weight gain. We used 16S rRNA gene sequencing to profile the composition and predicted metabolic functionality of the oropharyngeal microbiota in 8 piglets (4 with a birthweight ≤ 1.0 kg and 4 with a birthweight ≥ 1.7 kg) at 11, 26, and 63 days of age. We found 9 genera that were significantly associated with average daily gain (ADG) at 11 days (false discovery rate, FDR < 0.05) and 26 days of age (FDR < 0.1), respectively. The microbial functional profile revealed several pathways associated with ADG (FDR < 0.05). Among these, pathways related to degradation of catechols showed a positive association with ADG at 11, 26, and 63 days of age, implying a potential to breakdown the host-derived catecholamines. We also noted that pathways related to the biodegradation of nucleosides and nucleotides increased with ADG during the pre-weaning phase, while those involved in their biosynthesis decreased. Our findings provide insights into the oropharyngeal microbial memberships and metabolic pathways that are involved in a piglet's weight gain. Thus, providing a basis for the development of strategies aimed at improving weight gain in pigs. © Copyright 2020 Korean Society of Animal Science and Technology.Entities:
Keywords: Average daily gain; Birthweight; Microbiome; Oropharyngeal; Swine
Year: 2020 PMID: 32292932 PMCID: PMC7142290 DOI: 10.5187/jast.2020.62.2.247
Source DB: PubMed Journal: J Anim Sci Technol ISSN: 2055-0391
Fig. 1.Stacked bar graphs showing the phylogenetic composition of the oropharyngeal microbiota in high birthweight (HBW) vs low birthweight piglets (LBW) at 11, 26, and 63 days of age.
The comparison is made in (A) at phylum level, (B) at family level and (C) at genus level.
Fig. 2.Principle Coordinate Analysis (PCoA) plots illustrating the phylogenetic composition of the piglets’ oropharyngeal microbial community.
(A) Two dimensional PCoA plot based on unweighted UniFrac distances showing the distribution of the microbiota and 95% distribution ellipses at the 3 time points. (B) Three dimensional PCoA plots based on Bray Curtis distances showing the distribution of the oropharyngeal microbiota in samples collected at 11, 26, and 63 days of age. The symbols represent data from individual piglets and are color-coded by the indicated categories of metadata.
Fig. 3.Longitudinal analysis of microbial composition.
In (A) is a volatility plot of Shannon diversity showing changes in alpha diversity in high birth weight (HBW) and in low birth weight (LBW) piglets over the study period. In (B–C) are boxplots showing the paired distances in beta diversity of HBW and LBW piglets; (B) between 11 and 26 days of age and (C) between 11 and 63 days of age. The distances are based on the Bray Curtis distance matrices between each subject’s diversity at the given time points.
Genera that were significantly associated with ADG at 11 days of age
| Phylum;Class;Order;Family;Genus | logFC | logCPM | LR | FDR | ||
|---|---|---|---|---|---|---|
| 1 | Firm;Nega;Vell;Veil; | –14.67782 | 16.60199 | 15.9995 | 6.34E-05 | 0.004270 |
| 2 | Firm;Baci;Lact;Aero; | 26.99785 | 14.38829 | 15.87192 | 6.78E-05 | 0.004270 |
| 3 | Bact;Flav;Flav;[Wee]; | –37.34028 | 12.99741 | 14.98349 | 0.000108 | 0.004377 |
| 4 | Bact;Bact;Bact;[Par];[ | –18.82124 | 13.47373 | 14.85977 | 0.000116 | 0.004377 |
| 5 | Prot;Gamm;Pseu;Mora; | 49.12427 | 13.21755 | 13.95362 | 0.000187 | 0.005902 |
| 6 | Firm;Baci;Baci;Plan; | 24.61041 | 8.322315 | 10.81635 | 0.001006 | 0.027109 |
| 7 | Firm;Baci;Lact;Ente; | 35.18011 | 9.889504 | 10.57308 | 0.001147 | 0.027109 |
| 8 | Prot;Gamm;Pseu;Mora; | 18.29274 | 17.07745 | 10.1381 | 0.001452 | 0.030500 |
| 9 | Firm;Baci;Lact;Aero; | 19.61991 | 10.15351 | 9.796667 | 0.001748 | 0.033043 |
| 10 | Prot;Gamm;Past;Past; | –9.712501 | 14.02468 | 8.132637 | 0.004348 | 0.068474 |
| 11 | Firm;Baci;Baci;Plan; | 39.45043 | 10.27581 | 7.677588 | 0.005591 | 0.074895 |
| 12 | Bact;Bact;Bact;[Par]; | –27.74231 | 9.776943 | 7.637212 | 0.005718 | 0.074895 |
| 13 | Prot;Gamm;Past;Past; | –10.47806 | 11.74235 | 7.567197 | 0.005944 | 0.074895 |
Nine genera (Veillonella, Aerococcus, Bergeyella, Prevotella, Psychrobacter, Kurthia, Enterococcus, Acinetobacter and Facklamia) within the oropharyngeal microbiota were significantly associated with ADG at 11 days of age (FDR < 0.05).
[ ]; The names in square brackets [ ] within the Greengenes database are still contested at that taxonomic level.
ADG, average daily gain; logFC, log fold-change; logCPM, log counts per million; LR, likelihood ratio; FDR, false discovery rate (adjusted p-value).
Phylla; Cyan – Cyanobacteria, Firm – Firmicutes, Bact - Bacteroidetes, Prot – Proteobacteria. Classes; Nega – Negativicutes, Baci – Bacilli, Flav – Flavobacteriia, Bact – Bacteroidia, Gamm – Gammaproteobacteria, Alph- Alphaproteobacteria. Orders; Vell – Vellionellales, Lact – Lactobacilliales, Flav – Flavobacteriales, Bact – Bacteroidales, Pseu – Pseudomonadales, Baci – Bacillales, Lact – Lactobacillales, Past – Pasteurellales. Families; Veil – Veillonellaceae, Aero – Aerococcaceae, Mora – Moraxellaceae, Past – Pasteurellaceae, Plan – Planococcaceae, Past – Pasteurellaceae, Ente – Enterococcaceae.
Genera that were significantly associated with ADG at 26 days of age
| Phylum;Class;Order;Family;Genus | logFC | logCPM | LR | FDR | ||
|---|---|---|---|---|---|---|
| 1 | Firm;Clos;Clos;[Tis]; | –23.44355 | 14.17177 | 12.71057 | 0.000364 | 0.053548 |
| 2 | Acti;Acti;Acti;Derm; | –25.88382 | 7.692197 | 11.72411 | 0.000617 | 0.053548 |
| 3 | Firm;Baci;Lact;Aero; | 19.01275 | 14.38829 | 11.12881 | 0.00085 | 0.053548 |
| 4 | Bact;Bact;Bact;; | –14.66345 | 15.57125 | 9.673499 | 0.001869 | 0.088331 |
| 5 | Fuso;Fuso;Fuso;Lept; | –13.97292 | 14.54914 | 9.123524 | 0.002523 | 0.094253 |
| 6 | Firm;Erys;Erys;Erys;.1 | –16.66539 | 12.16592 | 8.465524 | 0.003619 | 0.094253 |
| 7 | Firm;Baci;Lact;Leuc; | 16.41927 | 9.654118 | 8.248555 | 0.004078 | 0.094253 |
| 8 | Acti;Acti;Acti;Diet; | 33.5106 | 7.878502 | 8.101699 | 0.004422 | 0.094253 |
| 9 | Acti;Acti;Acti;Acti; | –29.88175 | 10.98488 | 8.07491 | 0.004488 | 0.094253 |
| 10 | Prot;Gamm;Pseu;Mora; | 19.90006 | 13.21759 | 7.650028 | 0.005677 | 0.107298 |
Nine genera (Helcococcus, Helcobacillus, Aerococcus, Weissella, Dietzia, Arcanobacterium, and 3 unidentified genera) within the oropharyngeal microbiota were significantly associated with ADG at 26 days of age (FDR < 0.1). Because 3 sequence data of 16S RNA have not been identified in the phylogenetic level of genus in the Greengenes database, they are remarked as 3 unidentified genera.
ADG, average daily gain; logFC, log fold-change; logCPM, log counts per million; LR, likelihood ratio; FDR, false discovery rate (adjusted p-value).
[ ]; The name in square bracket [ ] within the Greengenes database is still contested at that taxonomic level.
Phylla; Firm – Firmicutes, Acti - Actinobacteria, Bact - Bacteroidetes, Fuso - Fusobacteria, Prot - Proteobacteria Classes; Clos- Clostridia, Acti - Actinobacteria, Baci - Bacilli, Bact - Bacteroidia, Fuso - Fusobacteriia, Erys - Erysipelotrichia, Gamm – Gammaproteobacteria. Orders; Clos- Clostridiales, Acti - Actinomycetales, Lact - Lactobacilliales, Bact – Bacteroidales, Fuso - Fusobacteriales, Erys - Erysipelotrichiales, Pseu – Pseudomonadales. Families; Derm - Dermabacteraceae, Aero – Aerococcaceae, Lept - Leptotrichiaceae, Erys - Erysipelotrichaceae, Leuc - Leuconostocaceae, Diet - Dietziaceae, Acti - Actinomycetaceae, Mora – Moraxellaceae.
Metabolic pathways that were significantly associated with ADG at 11 days of age
| Super pathway | Pathway | logFC | logCPM | LR | FDR | ||
|---|---|---|---|---|---|---|---|
| 1 | Nucleoside and nucleotide biosynthesis | Super pathway of pyrimidine nucleobases salvage | –0.839 | 13.071 | 29.653 | 5.17E-08 | 2.01E-05 |
| 2 | Generation of precursor metabolite and Energy | Pentose phosphate pathway (non-oxidative branch) | –0.824 | 13.094 | 20.929 | 4.77E-06 | 0.000590 |
| 3 | Aromatic compound degradation | Toluene degradation II (aerobic) (via 4-methylcatechol) | 16.045 | 8.814 | 20.366 | 6.40E-06 | 0.000590 |
| 4 | Aromatic compound degradation | Toluene degradation I (aerobic) (via o-cresol) | 16.044 | 8.814 | 20.323 | 6.54E-06 | 0.000590 |
| 5 | Aromatic compound degradation | Catechol degradation I (meta-cleavage pathway) | 18.976 | 8.614 | 20.040 | 7.58E-06 | 0.000590 |
| 6 | Amine and polyamine degradation | Allantoin degradation to glyoxylate III | 14.748 | 7.650 | 16.166 | 5.80E-05 | 0.003504 |
| 7 | Inorganic nutrient metabolism | Nitrate reduction VI (assimilatory) | –7.340 | 9.503 | 16.009 | 6.30E-05 | 0.003504 |
| 8 | Sugar acid metabolism | D-Galactarate degradation I | 8.898 | 4.542 | 14.948 | 0.000111 | 0.005055 |
| 9 | Sugar acid metabolism | D-Glucarate and D-galactarate degradation | 8.898 | 4.542 | 14.841 | 0.000117 | 0.005055 |
| 10 | Aromatic compound degradation | Catechol degradation III (ortho-cleavage pathway) | 28.587 | 8.951 | 14.399 | 0.000148 | 0.005266 |
| 11 | Aromatic compound degradation | Aromatic compounds degradation via β-ketoadipate | 28.588 | 8.951 | 14.386 | 0.000149 | 0.005266 |
| 12 | Aromatic compound degradation | Catechol degradation to β-ketoadipate | 28.386 | 8.809 | 14.070 | 0.000176 | 0.005294 |
| 13 | Fatty acid and lipid biosynthesis | Gondoate biosynthesis (anaerobic) | –0.793 | 13.048 | 13.932 | 0.000190 | 0.005294 |
| 14 | Nucleoside and nucleotide degradation | Adenosine nucleotides degradation II | 9.844 | 9.195 | 13.793 | 0.000204 | 0.005294 |
| 15 | Amino acid degradation | L-Tyrosine degradation I | 12.429 | 8.600 | 13.747 | 0.000209 | 0.005294 |
| 16 | Amine and polyamine degradation | Aromatic biogenic amine degradation (bacteria) | 19.374 | 6.380 | 13.671 | 0.000218 | 0.005294 |
| 17 | Aromatic compound degradation | Super pathway of salicylate degradation | 26.786 | 8.625 | 13.487 | 0.000240 | 0.005497 |
| 18 | Amino acid degradation | L-Leucine degradation I | 12.250 | 9.407 | 13.213 | 0.000278 | 0.005952 |
| 19 | Nucleoside and nucleotide degradation | Purine nucleotides degradation II (aerobic) | 8.390 | 9.712 | 13.129 | 0.000291 | 0.005952 |
| 20 | Sugar acid metabolism | D-Glucarate degradation I | 8.660 | 4.806 | 12.789 | 0.000349 | 0.006781 |
| 21 | Propanoate degradation | 2-Methylcitrate cycle I | 9.695 | 8.674 | 12.467 | 0.000414 | 0.007671 |
| 22 | Aromatic compound degradation | Cinnamate and 3-hydroxycinnamate degradation to 2-hydroxypentadienoate | 32.388 | 8.468 | 12.098 | 0.000505 | 0.008565 |
| 23 | Aromatic compound degradation | 3-Phenylpropanoate and 3-(3-hydroxyphenyl) propanoate degradation to 2-hydroxypentadienoate | 32.388 | 8.468 | 12.092 | 0.000506 | 0.008565 |
| 24 | Amine and polyamine degradation | Allantoin degradation IV (anaerobic) | 13.428 | 6.716 | 11.229 | 0.000805 | 0.013055 |
| 25 | Aromatic compound degradation | Meta cleavage pathway of aromatic compounds | 22.121 | 6.813 | 11.049 | 0.000888 | 0.013810 |
| 26 | Aromatic compound degradation | 3-Phenylpropanoate and 3-(3-hydroxyphenyl) propanoate degradation | 27.451 | 8.520 | 10.975 | 0.000924 | 0.013817 |
| 27 | Secondary metabolite degradation | Engineered pathway: isoprene biosynthesis II (engineered) | 12.333 | 4.357 | 10.740 | 0.001048 | 0.015103 |
| 28 | Nucleoside and nucleotide biosynthesis | Adenosine ribonucleotides de novo biosynthesis | –0.603 | 12.960 | 10.266 | 0.001355 | 0.018827 |
| 29 | Nucleoside and nucleotide biosynthesis | Super pathway of adenosine nucleotides de novo biosynthesis I | –0.693 | 12.986 | 10.005 | 0.001561 | 0.020945 |
| 30 | Aromatic compound degradation | 4-Methylcatechol degradation (ortho cleavage) | 27.042 | 8.601 | 9.596 | 0.001950 | 0.024940 |
| 31 | Aromatic compound degradation | Catechol degradation II (meta-cleavage pathway) | 12.723 | 6.818 | 9.561 | 0.001988 | 0.024940 |
| 32 | Aromatic compound degradation | Protocatechuate degradation II (ortho-cleavage pathway) | 10.463 | 8.309 | 9.373 | 0.002202 | 0.026766 |
| 33 | Sugar nucleotide biosynthesis | CMP-legionaminate biosynthesis I | –8.205 | 8.984 | 9.189 | 0.002434 | 0.028639 |
| 34 | Aromatic compound degradation | Phenylacetate degradation I (aerobic) | 20.830 | 8.727 | 9.138 | 0.002503 | 0.028639 |
| 35 | Aldehyde degradation | Super pathway of methylglyoxal degradation | 21.047 | 6.569 | 8.790 | 0.003029 | 0.033661 |
| 36 | Sugar biosynthesis | Sucrose biosynthesis III | 18.218 | 4.108 | 8.710 | 0.003165 | 0.034199 |
| 37 | Amine and polyamine biosynthesis | Ectoine biosynthesis | 15.114 | 3.587 | 8.505 | 0.003543 | 0.037244 |
| 38 | Amino acid degradation | L-arginine degradation II (AST pathway) | 12.522 | 4.822 | 8.097 | 0.004434 | 0.045390 |
| 39 | Cell structure biosynthesis | Peptidoglycan biosynthesis II (staphylococci) | 4.900 | 9.105 | 7.908 | 0.004922 | 0.048418 |
| 40 | Nucleoside and nucleotide biosynthesis | Super pathway of adenosine nucleotides de novo | –0.697 | 12.922 | 7.853 | 0.005073 | 0.048418 |
| 41 | Cell structure biosynthesis | UDP-N-acetylmuramoyl-pentapeptide biosynthesis I (meso-diaminopimelate containing) | –0.739 | 12.817 | 7.781 | 0.005280 | 0.048418 |
| 42 | Secondary metabolite degradation | Sulfoquinovose degradation I | 10.149 | 3.185 | 7.742 | 0.005395 | 0.048418 |
| 43 | Aromatic compound degradation | Catechol degradation to 2-hydroxypentadienoate II | 11.213 | 6.438 | 7.732 | 0.005425 | 0.048418 |
| 44 | Amino acid biosynthesis | L-Lysine biosynthesis II | –2.476 | 11.855 | 7.715 | 0.005477 | 0.048418 |
| 45 | Antibiotic resistance | Polymyxin resistance | 9.731 | 3.860 | 7.668 | 0.005621 | 0.048588 |
ADG, average daily gain; logFC, log fold-change; logCPM, log counts per million; LR, likelihood ratio; FDR, false discovery rate (adjusted p-value).
Metabolic pathways that were significantly associated with ADG at 63 days of age
| Super pathway | Pathway | logFC | logCPM | LR | FDR | ||
|---|---|---|---|---|---|---|---|
| 1 | Vitamin K2 biosynthesis | 1,4-Dihydroxy-6-naphthoate biosynthesis I | 43.60243 | 5.323691 | 13.81177 | 0.000202 | 0.041719 |
| 2 | Inorganic nutrient metabolism | Super pathway of sulphur oxidation
( | 27.23389 | 8.525369 | 13.69964 | 0.000214 | 0.041719 |
| 3 | Fatty acid and lipid degradation | Phospholipase pathway | –48.3973 | –0.97698 | 12.20301 | 0.000477 | 0.061867 |
| 4 | Vitamin K2 biosynthesis | 1,4-Dihydroxy-6-naphthoate biosynthesis II | 28.17554 | 6.774948 | 10.42818 | 0.001241 | 0.120694 |
| 5 | Aromatic compound degradation | Catechol degradation to 2-hydroxypentadienoate II | 17.00923 | 6.437778 | 7.659094 | 0.005649 | 0.407778 |
ADG, average daily gain; logFC, log fold-change; logCPM, log counts per million; LR, Likelihood ratio; FDR, False discovery rate (adjusted p-value).
Metabolic pathways that were significantly associated with ADG at 26 days of age
| Super pathway | Pathway | logFC | logCPM | LR | FDR | ||
|---|---|---|---|---|---|---|---|
| 1 | Aromatic compound degradation | Catechol degradation I (meta-cleavage pathway) | 15.28376 | 8.613798 | 19.28901 | 1.12E-05 | 0.00437 |
| 2 | Aromatic compound degradation | Catechol degradation to 2-hydroxypentadienoate II | 12.99083 | 6.437917 | 15.3016 | 9.16E-05 | 0.0148 |
| 3 | Aromatic compound degradation | Catechol degradation II (meta-cleavage pathway) | 12.94294 | 6.817753 | 14.8872 | 0.000114 | 0.0148 |
| 4 | Fatty acid and lipid biosynthesis | Super pathway of lipopolysaccharide biosynthesis | 28.38013 | 2.42697 | 13.50893 | 0.000237 | 0.02309 |
| 5 | Aromatic compound degradation | Toluene degradation II (aerobic) (via 4-methylcatechol) | 10.58863 | 8.813538 | 12.74445 | 0.000357 | 0.023322 |
| 6 | Aromatic compound degradation | Toluene degradation I (aerobic) (via o-cresol) | 10.58859 | 8.813538 | 12.73057 | 0.00036 | 0.023322 |
| 7 | Sugar acid metabolism | D-Galactarate degradation I | 8.848847 | 4.542388 | 11.51003 | 0.000692 | 0.031156 |
| 8 | Antibiotic resistance | Polymyxin resistance | 15.29624 | 3.859829 | 11.46961 | 0.000707 | 0.031156 |
| 9 | Sugar acid metabolism | Super pathway of D-glucarate and D-Galactarate degradation | 8.848833 | 4.542388 | 11.43476 | 0.000721 | 0.031156 |
| 10 | Nucleoside and nucleotide biosynthesis | Super pathway of pyrimidine nucleobases salvage | –0.46889 | 13.07049 | 10.52772 | 0.001176 | 0.045745 |
| 11 | Sugar acid metabolism | D-glucarate degradation I | 8.936948 | 4.805885 | 10.33191 | 0.001307 | 0.046238 |
| 12 | Amine and polyamine degradation | Allantoin degradation IV (anaerobic) | 12.94646 | 6.715548 | 9.796436 | 0.001749 | 0.051378 |
ADG, average daily gain; logFC, log fold-change; logCPM, log counts per million; LR, likelihood ratio; FDR, false discovery rate (adjusted p-value).